Paracetamol fails quality test, hospitals halt distribution

Two commonly used medicines — including paracetamol, a widely taken fever and pain reliever — failed government quality tests in Nagpur, India. In response, government hospitals in the city stopped distributing the drugs and pulled affected stock from circulation, recalling around 1.25 lakh (125,000) paracetamol tablets. The recall matters because government hospitals serve large numbers of people who rely on free or low-cost medicines, so even a short disruption can affect access to basic treatment. Coverage so far is limited to neutral reporting of the recall itself; the identity of the second medication, the manufacturer, and the specific reason the batches failed have not been detailed in the available reports. It is also not yet clear whether patients who already received the tablets face any health risk. What to watch: the regulator's test findings, any identification of the manufacturer, and whether the recall expands beyond Nagpur's government facilities.